Skip to main content

and
  1. Article

    Open Access

    Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

    Molecular characterisation of single circulating tumour cells (CTCs) holds considerable promise for predictive biomarker assessment and to explore CTC heterogeneity. We evaluate a new method, the DEPArray syst...

    D J E Peeters, B De Laere, G G Van den Eynden, S J Van Laere in British Journal of Cancer (2013)

  2. Article

    Open Access

    Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer

    The enumeration of circulating tumour cells (CTC) has prognostic significance in patients with metastatic breast cancer (MBC) and monitoring of CTC levels over time has considerable potential to guide treatmen...

    D J E Peeters, G G Van den Eynden, P-J van Dam, A Prové in British Journal of Cancer (2011)

  3. Article

    Open Access

    Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype

    Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter occurs in about 40% of breast tumours and has been correlated with reduced APC protein levels. To what extent epigenetic alterations of t...

    I Van der Auwera, S J Van Laere, S M Van den Bosch in British Journal of Cancer (2008)

  4. Article

    Open Access

    NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation

    Activation of NF-κB in inflammatory breast cancer (IBC) is associated with loss of estrogen receptor (ER) expression, indicating a potential crosstalk between NF-κB and ER. In this study, we examined the activ...

    S J Van Laere, I Van der Auwera, G G Van den Eynden, P van Dam in British Journal of Cancer (2007)

  5. Article

    Open Access

    High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT–PCR mRNA expression profile

    Clear cell renal cell carcinoma (CC-RCC) is a highly vascularised tumour and is therefore an attractive disease to study angiogenesis and to test novel angiogenesis inhibitors in early clinical development. En...

    M M Baldewijns, V L Thijssen, G G Van den Eynden in British Journal of Cancer (2007)

  6. Article

    Open Access

    Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer

    We studied the presence of lymphangiogenesis in lymph node (LN) metastases of breast cancer. Lymph vessels were present in 52 of 61 (85.2%) metastatically involved LNs vs 26 of 104 (25.0%) uninvolved LNs (P<0.001...

    G G Van den Eynden, I Van der Auwera, S J Van Laere in British Journal of Cancer (2006)

  7. Article

    Open Access

    Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study

    Recently, peritumoural (lympho)vascular invasion, assessed on haematoxylin–eosin (HE)-stained slides, was added to the St Gallen criteria for adjuvant treatment of patients with operable breast cancer (BC). Ne...

    G G Van den Eynden, I Van der Auwera, S J Van Laere in British Journal of Cancer (2006)

  8. Article

    Open Access

    Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer

    Hypoxia and angiogenesis are important factors in breast cancer progression. Little is known of hypoxia and angiogenesis in lymph node metastases of breast cancer. The aim of this study was to quantify hypoxia...

    G G Van den Eynden, I Van der Auwera, S J Van Laere in British Journal of Cancer (2005)

  9. Article

    Open Access

    Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer

    Adjuvant treatment of patients with colorectal cancer is hampered by a lack of reliable prognostic factors in addition to the clinicopathological staging system. A poorly defined but considerable fraction of A...

    P B Vermeulen, G G Van den Eynden, P Huget, G Goovaerts in British Journal of Cancer (1999)